DCM
AKBA icon

DAFNA Capital Management’s Akebia Therapeutics AKBA Stock Holding History

DAFNA Capital Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-341,779
Closed -$858K – 75
2020
Q3 		$858K Sell
341,779
-420,887
-55% -$3.69M 0.28% 58
2020
Q2 		$10.4M Sell
762,666
-90,872
-11% -$940K 2.99% 6
2020
Q1 		$6.47M Buy
853,538
+83,000
+11% +$646K 2.7% 11
2019
Q4 		$4.87M Sell
770,538
-57,500
-7% -$273K 1.67% 15
2019
Q3 		$3.25M Sell
828,038
-2,500
-0.3% -$10.7K 1.22% 25
2019
Q2 		$4.02M Buy
830,538
+115,000
+16% +$654K 1.51% 20
2019
Q1 		$5.86M Hold
715,538
– – 2.53% 10
2018
Q4 		$3.96M Buy
715,538
+89,800
+14% +$703K 1.97% 15
2018
Q3 		$5.53M Buy
625,738
+15,000
+2% +$134K 2.27% 10
2018
Q2 		$6.09M Hold
610,738
– – 2.85% 8
2018
Q1 		$5.82M Buy
610,738
+475,000
+350% +$6.64M 2.83% 8
2017
Q4 		$2.02M Hold
135,738
– – 1.09% 31
2017
Q3 		$2.67M Hold
135,738
– – 1.66% 20
2017
Q2 		$1.95M Buy
135,738
+65,283
+93% +$827K 1.39% 25
2017
Q1 		$648K Buy
+70,455
New +$688K 0.55% 51
2016
Q3 		– Sell
-24,700
Closed -$185K – 80
2016
Q2 		$185K Sell
24,700
-41,000
-62% -$358K 0.15% 80
2016
Q1 		$592K Buy
+65,700
New +$533K 0.51% 57

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

DAFNA Capital Management's AKBA Position: Q4 2020 in Review

DAFNA Capital Management sold out of Akebia Therapeutics (AKBA) in Q4 2020, closing a stake of 341,779 shares — an estimated $858K sold.

DAFNA Capital Management first reported a position in AKBA in Q1 2016 and held it in 17 quarters. The position peaked at $10.4M in Q2 2020. 143 funds tracked by Wall St. Rank hold AKBA as of Q4 2020.

  • DAFNA Capital Management reported no remaining Akebia Therapeutics position as of Q4 2020 after selling out during the quarter.
  • DAFNA Capital Management sold 341,779 Akebia Therapeutics shares in Q4 2020, an estimated $858K.
  • DAFNA Capital Management first reported a position in Akebia Therapeutics in Q1 2016 and held it in 17 quarters.
  • DAFNA Capital Management's Akebia Therapeutics position peaked at $10.4M in Q2 2020.
  • 143 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2020.

Based on DAFNA Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.